Accord Healthcare is a wholly owned subsidiary of Intas Pharmaceutical; a vertically integrated global pharmaceutical company specializing in the research, development and manufacturing of APIs, Generic Medicines and Biopharmaceuticals. Operating in Canada since 2009, Accord Healthcare is committed to providing high quality, cost effective generic medicines to Canadian patients. Our global presence and vertically integrated production network enable Accord Healthcare to support the Canadian market with more than 50 oral solid and injectable medicines across numerous therapeutic categories.

With commercial offices in Toronto and Montreal, as well as a clinical research facility, Novum Pharmaceutical Research Services , in Toronto, Accord Healthcare has developed a strong presence across the Canadian pharmaceutical landscape. In recent years, Accord Healthcare has emerged as a dynamic pharmaceutical company that is continuously enhancing product and service offerings to ensure best-in-class quality and safety. As one of the fastest growing companies in the Canadian generic pharmaceutical sector, Accord Healthcare is poised to innovate and evolve to meet the challenges faced by Canadian patients now and in the future.